Thursday, March 28, 2024 | Ramadan 17, 1445 H
broken clouds
weather
OMAN
23°C / 23°C
EDITOR IN CHIEF- ABDULLAH BIN SALIM AL SHUEILI

Merck to buy Peloton for $1.05 billion

1224876
1224876
minus
plus

BENGALURU: Merck & Co Inc said on Tuesday it would buy Peloton Therapeutics Inc for $1.05 billion in cash to gain access to the privately held company’s renal cancer drug candidate.


The company’s lead drug candidate, PT2977, will be studied in a late-stage study for treating renal cell carcinoma.


Peloton shareholders will be eligible to receive a further $1.15 billion on achieving certain milestones.


The company had been looking to go public and gave a pricing range of $15 to $17 per share for its initial public offering last week. Credit Suisse acted as financial adviser for Merck and Covington & Burling LLP as its legal adviser. — Reuters


SHARE ARTICLE
arrow up
home icon